Actively Recruiting
Advancing Cervical Cancer Screening Through Emergency Department-based Self-Sampling
Led by University of Rochester · Updated on 2026-05-04
200
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the use of self-sampling for cervical cancer screening in the emergency department (ED) among women and transgender/non-binary individuals with a cervix aged 30 to 65 years. This single-arm pilot trial aims to compare how many patients complete cervical cancer screening through HPV self-sampling during their ED visit, addressing barriers to care and participant experiences with this method. Follow-up will assess screening activity and related outcomes about 150 days after enrollment. Participants will be given instructions on how to self-sample for HPV using a swab during their ED visit. They can perform the sample collection privately, either in their ED room or a private restroom. After sampling, the swabs are sent to a laboratory for analysis. Those who choose not to or cannot complete self-sampling will still remain in the study and be referred for clinic-based screening. Participants who are already adherent to screening guidelines will have their participation ended after a screening survey. During the study, participants will complete a survey and follow-up at 150 days will gather information on cervical cancer screening activity, barriers to care, and experiences with the intervention. Researchers will review electronic health records to verify screening activities and clinical testing completion. The primary outcome is the uptake of cervical cancer screening through self-sampling in the ED, monitored approximately 150 days after enrollment.
CONDITIONS
Brief Title
Emergency Department-based Cervical Cancer Screening Through Self-sampling
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Cisgender women and transgender/non-binary individuals with a cervix
- Age 30 to 65 years
- Ability to consent to participate with decisional capacity
- No known exclusion criteria present
You will not qualify if you...
- Past hysterectomy with removal of the cervix
- Known HIV infection
- Inability to consent (e.g., intoxicated, in distress, or lacking decisional capacity)
- Current pregnancy or within three months postpartum
- Use of vaginal ovules, creams, washes, contraceptives, or condoms within past 3 days
- Sexual intercourse, transvaginal ultrasound, or gynecological exam within past 2 days
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) during the emergency department visit
Duration - Approximately 150 days
Participants who complete self-sampling are observed to determine cervical cancer screening activity, barriers to care, and experiences with the intervention.
1 follow-up contact at about 150 days after enrollment
Trial Site Locations
Total: 1 location
1
University of Rochester Strong Memorial Hospital
Rochester, New York, United States, 14642
Actively Recruiting
Research Team
R
Research Administrator
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here